Connor, Clark & Lunn Investment Management Ltd. Amphastar Pharmaceuticals, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 83,673 shares of AMPH stock, worth $3.05 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
83,673
Previous 104,121
19.64%
Holding current value
$3.05 Million
Previous $4.16 Million
2.5%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
36.5MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$217 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$99 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$77.9 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$71.1 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$59 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.79B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...